US Patent Issued to BIOSION on Sept. 1 for "Monoclonal antibodies which bind PD-1, encoding nucleotides thereof and method of use thereof to treat cancer, infectious disease and inflammatory disease" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,082, issued on Sept. 1, was assigned to BIOSION INC. (Nanjing, China).

"Monoclonal antibodies which bind PD-1, encoding nucleotides thereof and method of use thereof to treat cancer, infectious disease and inflammatory disease" was invented by Mingjiu Chen (Nanjing, China), Shukai Xia (Nanjing, China), Mark Zhiqing Ma (Nanjing, China) and Zeyu Peng (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "An isolated monoclonal antibody that specifically binds human PD-1, or the antigen-binding portion thereof. A nucleic acid molecule encoding the antibody or the antigen-binding portion thereof, an expression vector, a host cell and a method fo...